Riverhead Capital Management’s Insmed INSM Stock Holding History

Riverhead Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,863	Closed	-$73K	–	1520
2019 Q2	$73K	Buy	+2,863	New	+$79.8K	﹤0.01%	1398

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Riverhead Capital Management's INSM Position: Q3 2019 in Review

Riverhead Capital Management sold out of Insmed (INSM) in Q3 2019, closing a stake of 2,863 shares — an estimated $73K sold.

Riverhead Capital Management first reported a position in INSM in Q2 2019 and held it in 1 quarter. The position peaked at $73K in Q2 2019. 157 funds tracked by Wall St. Rank hold INSM as of Q3 2019.

Riverhead Capital Management reported no remaining Insmed position as of Q3 2019 after selling out during the quarter.
Riverhead Capital Management sold 2,863 Insmed shares in Q3 2019, an estimated $73K.
Riverhead Capital Management first reported a position in Insmed in Q2 2019 and held it in 1 quarter.
Riverhead Capital Management's Insmed position peaked at $73K in Q2 2019.
157 funds tracked by Wall St. Rank held Insmed as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.